ATE490265T1 - Schwefelverbindungen als hemmer der ns3-serin- protease des hepatitis-c-virus - Google Patents
Schwefelverbindungen als hemmer der ns3-serin- protease des hepatitis-c-virusInfo
- Publication number
- ATE490265T1 ATE490265T1 AT08742663T AT08742663T ATE490265T1 AT E490265 T1 ATE490265 T1 AT E490265T1 AT 08742663 T AT08742663 T AT 08742663T AT 08742663 T AT08742663 T AT 08742663T AT E490265 T1 ATE490265 T1 AT E490265T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatitis
- virus
- inhibitors
- serine protease
- sulfur compounds
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 102000012479 Serine Proteases Human genes 0.000 title 1
- 108010022999 Serine Proteases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000003464 sulfur compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/733,479 US7816326B2 (en) | 2004-02-27 | 2007-04-10 | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
| PCT/US2008/004549 WO2008124148A2 (en) | 2007-04-10 | 2008-04-08 | Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE490265T1 true ATE490265T1 (de) | 2010-12-15 |
Family
ID=39743035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08742663T ATE490265T1 (de) | 2007-04-10 | 2008-04-08 | Schwefelverbindungen als hemmer der ns3-serin- protease des hepatitis-c-virus |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7816326B2 (de) |
| EP (1) | EP2134739B1 (de) |
| JP (1) | JP2010523666A (de) |
| KR (1) | KR20100016185A (de) |
| CN (1) | CN101679484A (de) |
| AR (1) | AR065984A1 (de) |
| AT (1) | ATE490265T1 (de) |
| AU (1) | AU2008236644A1 (de) |
| BR (1) | BRPI0810851A2 (de) |
| CA (1) | CA2683639A1 (de) |
| CL (1) | CL2008001005A1 (de) |
| CO (1) | CO6231036A2 (de) |
| DE (1) | DE602008003777D1 (de) |
| EC (1) | ECSP099685A (de) |
| ES (1) | ES2355015T3 (de) |
| IL (1) | IL201427A0 (de) |
| MX (1) | MX2009011064A (de) |
| PE (1) | PE20090228A1 (de) |
| RU (1) | RU2009141187A (de) |
| TW (1) | TW200902044A (de) |
| WO (1) | WO2008124148A2 (de) |
| ZA (1) | ZA200907353B (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491794B2 (en) * | 2003-10-14 | 2009-02-17 | Intermune, Inc. | Macrocyclic compounds as inhibitors of viral replication |
| MY145081A (en) * | 2004-02-27 | 2011-12-15 | Schering Corp | Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| US7816326B2 (en) * | 2004-02-27 | 2010-10-19 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
| JP5249028B2 (ja) * | 2005-07-25 | 2013-07-31 | インターミューン・インコーポレーテッド | Ｃ型肝炎ウイルス複製の新規大環状阻害剤 |
| GEP20104956B (en) * | 2005-10-11 | 2010-04-12 | Array Biopharma Inc | Compounds for inhibiting hepatitis c viral replication and use thereof |
| KR20110005869A (ko) * | 2008-04-15 | 2011-01-19 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규한 마크로사이클릭 억제제 |
| CN102216321A (zh) * | 2008-10-15 | 2011-10-12 | 因特蒙公司 | 治疗性抗病毒肽 |
| AR075584A1 (es) | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
| CA2763140A1 (en) | 2009-05-29 | 2010-12-02 | Schering Corporation | Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c |
| AU2010324871A1 (en) | 2009-11-25 | 2012-06-14 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases |
| CA2785488A1 (en) | 2009-12-22 | 2011-07-21 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases |
| EP2545060B1 (de) | 2010-03-09 | 2015-11-25 | Merck Sharp & Dohme Corp. | Kondensierte tricyclische silylverbindngen und verfahren zu deren verwendung zur behandlung von viralen krankheiten |
| WO2012018534A2 (en) | 2010-07-26 | 2012-02-09 | Schering Corporation | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases |
| EP2621279B1 (de) | 2010-09-29 | 2018-04-04 | Merck Sharp & Dohme Corp. | Kondensierte tetrazyklische derivate und verfahren zu ihrer verwendung zur behandlung von virenerkrankungen |
| US9156872B2 (en) | 2011-04-13 | 2015-10-13 | Merck Sharp & Dohme Corp. | 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
| EP2696681B1 (de) | 2011-04-13 | 2018-10-03 | Merck Sharp & Dohme Corp. | 2'-substituierte nukleosidderivate und verfahren zu ihrer verwendung zur behandlung von virenerkrankungen |
| WO2013033900A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
| WO2013033901A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases |
| WO2013033899A1 (en) | 2011-09-08 | 2013-03-14 | Merck Sharp & Dohme Corp. | Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases |
| WO2013039876A1 (en) | 2011-09-14 | 2013-03-21 | Merck Sharp & Dohme Corp. | Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| BR112014012739A8 (pt) * | 2011-11-29 | 2017-06-20 | Gilead Pharmasset Llc | composições e métodos para o tratamento do vírus da hepatite c |
| US10167298B2 (en) | 2013-10-30 | 2019-01-01 | Merck Sharp & Dohme Corp. | Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof |
| WO2017059446A1 (en) | 2015-10-01 | 2017-04-06 | Memorial Sloan-Kettering Cancer Center | Anthranilyl-adenosinemonosulfamate analogs and uses thereof |
| CA3000709A1 (en) * | 2015-10-01 | 2017-04-06 | Memorial Sloan-Kettering Cancer Center | Inhibitors of menaquinone biosynthesis |
| EP3897667A4 (de) | 2018-12-21 | 2023-04-19 | Memorial Sloan Kettering Cancer Center | Salicyl-adenosin-monosulfamat-analoga und ihre verwendungen |
| WO2022013684A1 (en) | 2020-07-11 | 2022-01-20 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69133617D1 (de) * | 1990-04-04 | 2009-07-23 | Novartis Vaccines & Diagnostic | Protease von Hepatitis C Virus |
| US5922757A (en) | 1996-09-30 | 1999-07-13 | The Regents Of The University Of California | Treatment and prevention of hepatic disorders |
| CZ298749B6 (cs) | 1996-10-18 | 2008-01-16 | Vertex Pharmaceuticals Incorporated | Inhibitory serinových proteáz a farmaceutické prostředky s jejich obsahem |
| GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
| EP1012180B1 (de) | 1997-08-11 | 2004-12-01 | Boehringer Ingelheim (Canada) Ltd. | Peptidanaloga mit inhibitorischer wirkung auf hepatitis c |
| AR022061A1 (es) | 1998-08-10 | 2002-09-04 | Boehringer Ingelheim Ca Ltd | Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos. |
| US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
| US6608027B1 (en) * | 1999-04-06 | 2003-08-19 | Boehringer Ingelheim (Canada) Ltd | Macrocyclic peptides active against the hepatitis C virus |
| JP4806154B2 (ja) | 2000-04-03 | 2011-11-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | セリンプロテアーゼ、特にｃ型肝炎ウイルスｎｓ３プロテアーゼのインヒビター |
| JP4748911B2 (ja) | 2000-04-05 | 2011-08-17 | シェーリング コーポレイション | Ｎ−環状ｐ２部分を含むｃ型肝炎ウイルスの大環状ｎｓ３‐セリンプロテアーゼ阻害剤 |
| NZ521456A (en) | 2000-04-19 | 2004-07-30 | Schering Corp | Macrocyclic NS3-Serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| CA2418199A1 (en) | 2000-07-21 | 2002-01-31 | Corvas International, Inc. | Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| US7244721B2 (en) * | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| WO2002008187A1 (en) | 2000-07-21 | 2002-01-31 | Schering Corporation | Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| MXPA03000627A (es) | 2000-07-21 | 2004-07-30 | Schering Corp | Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c. |
| AR029851A1 (es) | 2000-07-21 | 2003-07-16 | Dendreon Corp | Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c |
| HUP0303436A2 (hu) * | 2000-12-12 | 2004-01-28 | Schering Corp. | Diaril-peptidek mint a hepatitis C vírus NS3-szerin proteáz inhibitorai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| US7816326B2 (en) | 2004-02-27 | 2010-10-19 | Schering Corporation | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease |
| MY145081A (en) | 2004-02-27 | 2011-12-15 | Schering Corp | Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| CN101212970B (zh) | 2005-06-02 | 2010-07-21 | 先灵公司 | Hcv蛋白酶抑制剂与表面活性剂的组合物 |
-
2007
- 2007-04-10 US US11/733,479 patent/US7816326B2/en active Active
-
2008
- 2008-04-08 AR ARP080101450A patent/AR065984A1/es unknown
- 2008-04-08 WO PCT/US2008/004549 patent/WO2008124148A2/en not_active Ceased
- 2008-04-08 AU AU2008236644A patent/AU2008236644A1/en not_active Abandoned
- 2008-04-08 ES ES08742663T patent/ES2355015T3/es active Active
- 2008-04-08 EP EP08742663A patent/EP2134739B1/de not_active Not-in-force
- 2008-04-08 BR BRPI0810851-0A2A patent/BRPI0810851A2/pt not_active Application Discontinuation
- 2008-04-08 CN CN200880019227A patent/CN101679484A/zh active Pending
- 2008-04-08 AT AT08742663T patent/ATE490265T1/de not_active IP Right Cessation
- 2008-04-08 DE DE602008003777T patent/DE602008003777D1/de active Active
- 2008-04-08 JP JP2010503039A patent/JP2010523666A/ja not_active Withdrawn
- 2008-04-08 PE PE2008000629A patent/PE20090228A1/es not_active Application Discontinuation
- 2008-04-08 CA CA002683639A patent/CA2683639A1/en not_active Abandoned
- 2008-04-08 RU RU2009141187/04A patent/RU2009141187A/ru not_active Application Discontinuation
- 2008-04-08 MX MX2009011064A patent/MX2009011064A/es active IP Right Grant
- 2008-04-08 KR KR1020097022983A patent/KR20100016185A/ko not_active Withdrawn
- 2008-04-09 CL CL200801005A patent/CL2008001005A1/es unknown
- 2008-04-09 TW TW097112895A patent/TW200902044A/zh unknown
-
2009
- 2009-10-08 EC EC2009009685A patent/ECSP099685A/es unknown
- 2009-10-09 CO CO09112538A patent/CO6231036A2/es not_active Application Discontinuation
- 2009-10-11 IL IL201427A patent/IL201427A0/en unknown
- 2009-10-20 ZA ZA200907353A patent/ZA200907353B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP099685A (es) | 2009-11-30 |
| MX2009011064A (es) | 2009-10-29 |
| CL2008001005A1 (es) | 2008-10-17 |
| US7816326B2 (en) | 2010-10-19 |
| ZA200907353B (en) | 2010-07-28 |
| KR20100016185A (ko) | 2010-02-12 |
| WO2008124148A3 (en) | 2009-05-07 |
| JP2010523666A (ja) | 2010-07-15 |
| EP2134739A2 (de) | 2009-12-23 |
| EP2134739B1 (de) | 2010-12-01 |
| CA2683639A1 (en) | 2008-10-16 |
| BRPI0810851A2 (pt) | 2014-10-29 |
| CO6231036A2 (es) | 2010-12-20 |
| DE602008003777D1 (de) | 2011-01-13 |
| ES2355015T3 (es) | 2011-03-22 |
| IL201427A0 (en) | 2010-05-31 |
| AU2008236644A1 (en) | 2008-10-16 |
| PE20090228A1 (es) | 2009-03-28 |
| US20070197448A1 (en) | 2007-08-23 |
| CN101679484A (zh) | 2010-03-24 |
| WO2008124148A2 (en) | 2008-10-16 |
| RU2009141187A (ru) | 2011-05-20 |
| TW200902044A (en) | 2009-01-16 |
| AR065984A1 (es) | 2009-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602008003777D1 (de) | Schwefelverbindungen als hemmer der ns3-serin-protease des hepatitis-c-virus | |
| DE602005021760D1 (de) | Schwefelverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus | |
| ATE434621T1 (de) | Neue verbindungen als inhibitoren der ns3- serinprotease des hepatitis-c-virus | |
| DE602005015452D1 (de) | Substituierte proline als hemmer der ns3-serinprotease des hepatits-c-virus | |
| ATE494288T1 (de) | Makrozyklische hemmer des hepatitis-c-virus | |
| CY2015014I2 (el) | Μακροκυκλικοι αναστολεις της πρωτεασης σερινης της ηπατιτιδας c | |
| LTPA2016049I1 (lt) | Makrocikliniai kvinoksalino junginiai kaip HCV NS3 proteazės inhibitoriai | |
| EP2125870A4 (de) | Inhibitoren von hepatitis-c-ns3-protease | |
| ATE524475T1 (de) | Makrocyclische inhibitoren des hepatitis-c-virus | |
| ATE496908T1 (de) | Makrocyclische inhibitoren des hepatitis-c-virus | |
| ATE455775T1 (de) | Makrocyclische inhibitoren des hepatitis-c-virus | |
| ATE517902T1 (de) | Makrocyclische inhibitoren des hepatitis-c-virus | |
| IL177545A0 (en) | Compounds as inhibitors of hepatitis c virus ns3 serine protease | |
| ATE496042T1 (de) | Makrocyclische inhibitoren des hepatitis-c-virus | |
| ATE496934T1 (de) | Makrocyclische inhibitoren des hepatitis-c-virus | |
| DE602006009280D1 (de) | Inhibitoren der hcv-ns3-protease | |
| ATE438622T1 (de) | 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus | |
| DE602004031298D1 (de) | Makrocyclische inhibitoren der ns3-serinprotease des hepatitis-c-virus | |
| HK1134306A (en) | Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |